The development of hepatic granulomas following interferon-alpha2b therapy for chronic hepatitis C infection. (Record no. 9818139)

MARC details
000 -LEADER
fixed length control field 01391 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513160007.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0954-691X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00042737-199804000-00013
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ryan, B M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990203
245 00 - TITLE STATEMENT
Title The development of hepatic granulomas following interferon-alpha2b therapy for chronic hepatitis C infection.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of gastroenterology & hepatology
Date of publication, distribution, etc. Apr 1998
300 ## - PHYSICAL DESCRIPTION
Extent 349-51 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemical and Drug Induced Liver Injury
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Granuloma
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon alpha-2
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-alpha
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Diseases
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McDonald, G S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pilkington, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kelleher, D
773 0# - HOST ITEM ENTRY
Title European journal of gastroenterology & hepatology
Related parts vol. 10
-- no. 4
-- p. 349-51
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00042737-199804000-00013">https://doi.org/10.1097/00042737-199804000-00013</a>
Public note Available from publisher's website

No items available.